1. New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy

   • Geraldo Bezerra da Silva Junior
   • Alexandre Braga Libório
   • Elizabeth De Francesco Daher

   Review Article 08 September 2011 Pages: 1371 - 1379

   

2. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma

   • Márk Plander
   • Peter Ugocsai
   • Gero Brockhoff

   Original Article 05 April 2011 Pages: 1381 - 1390

   

3. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes

   • Taekyu Lim
   • Seok Jin Kim
   • Won Seog Kim

   Original Article Open access 09 April 2011 Pages: 1391 - 1398

4. Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results

   • Harinder Gill
   • Chor-Sang Chim
   • Yok-Lam Kwong

   Original Article Open access 08 April 2011 Pages: 1399 - 1407

   

5. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

   • Ji-Won Kim
   • Byung-Su Kim
   • on behalf of the Korean Society of Blood and Marrow Transplantation

   Original Article 06 April 2011 Pages: 1409 - 1418

   

6. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins

   • Deok-Hwan Yang
   • Mi-Hyun Kim
   • Je-Jung Lee

   Original Article 05 April 2011 Pages: 1419 - 1426

   

7. Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

   • Silvia G. R. Verelst
   • F. Termorshuizen
   • Dutch-Belgium Hemato-Oncology Cooperative Group (HOVON)

   Original Article 07 April 2011 Pages: 1427 - 1439

   

8. Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma

   • Marta Krejci
   • Evzen Gregora
   • Roman Hajek

   Original Article 05 March 2011 Pages: 1441 - 1447

   

9. Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma

   • Massimo Offidani
   • Laura Corvatta
   • Pietro Leoni

   Original Article 25 March 2011 Pages: 1449 - 1456

   

10. Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients

    • Peter Schlenke
    • Wibke Hagenah
    • Thomas Wagner

    Original Article 19 April 2011 Pages: 1457 - 1465

    

11. Serum cortisol and inflammatory response in neutropenic fever

    • Auni Juutilainen
    • Sari Hämäläinen
    • Esa Jantunen

    Original Article 25 March 2011 Pages: 1467 - 1475

    

12. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia

    • Jean-Valère Malfuson
    • Johanna Konopacki
    • Thierry de Revel

    Letter to the Editor 25 February 2011 Pages: 1477 - 1479

    

13. A solitary pulmonary lymphomatoid granulomatosis-like lesion as the only manifestation of post-transplant lymphoproliferative disorder after hematopoietic stem-cell transplantation

    • Sheng-Hsiang Yang
    • Yi-Chen Yeh
    • Liang-Tsai Hsiao

    Letter to the Editor 02 March 2011 Pages: 1481 - 1483

    

14. Role of PET/CT screening in detecting a second primary carcinoma in patients with malignant lymphoma

    • Reona Sakemura
    • Junji Hiraga
    • Shinichi Mizuno

    Letter to the Editor 01 March 2011 Pages: 1485 - 1486

15. Bilateral irreversible blindness in leukaemic meningitis: cause or cure?

    • Christos Tziotzios
    • George Follows
    • Charles Crawley

    Letter to the Editor 04 March 2011 Pages: 1487 - 1488

    

16. FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings

    • Yukihiro Miyazaki
    • Yuichiro Nawa
    • Masamichi Hara

    Letter to the Editor 01 March 2011 Pages: 1489 - 1490

    

17. Intravenous busulfan-induced reversible leukoencephalopathy syndrome

    • Tomonori Nakazato
    • Yukinari Sanada
    • Yoshinobu Aisa

    Letter to the Editor 05 March 2011 Pages: 1491 - 1492

    

18. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid

    • Hongyan Tong
    • Kongfei Li
    • Jie Jin

    Letter to the Editor 23 March 2011 Pages: 1493 - 1494